EN / 中文

About LTZ

An Immunotherapy - Focused Biotech

LTZ Therapeutics is an immunotherapy-focused biotech company pursuing the development of novel therapies to improve clinical outcomes in patients with cancer and other diseases with an unmet clinical need. With main operations in Palo Alto California and Shenzhen China as well as Heidelberg Germany, LTZ is dedicated to developing immunotherapies capable of overcoming resistance and boosting anti-tumor immunity based on reverse translational science and emerging biology of tumor microenvironment.

A global facing company with a management team of seasoned drug developers.

Palo Alto (Bay Area), USA

Functions: discovery & research, early clinical development

Heidelberg, Germany

Functions:(reverse) translational sciences, SAB

Shenzhen, China

Functions: reverse translational sciences, CMC, early clinical development